Nu Skin Enterprises, Inc.
NUS- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001021561
No open-market purchases or sales by Nu Skin Enterprises, Inc. insiders were filed in the last 90 days; 162 institutions reported holding it in 13F filings for Q2 2026, worth $191.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Nu Skin Enterprises, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 212
- 0 vs. Q3 2023
- Shares held
- 40.9M
- −102.4K (−0.2%) vs. Q3 2023
- Total value
- $794.4M
- −$75.6M (−8.7%) vs. Q3 2023
- New holders
- 32
- 66 more added
- Sold out
- 32
- 84 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 162 | $191.1M |
| Q1 2026 | 178 | $264.8M |
| Q4 2025 | 187 | $354.8M |
| Q3 2025 | 194 | $441.6M |
| Q2 2025 | 180 | $289.7M |
| Q1 2025 | 195 | $263.7M |
| Q4 2024 | 201 | $259.4M |
| Q3 2024 | 203 | $285.1M |
| Q2 2024 | 202 | $442.8M |
| Q1 2024 | 198 | $548.1M |
| Q4 2023 | 212 | $794.4M |
| Q3 2023 | 212 | $870.1M |
| Q2 2023 | 219 | $1.43B |
| Q1 2023 | 205 | $1.77B |
| Q4 2022 | 218 | $1.89B |
| Q3 2022 | 207 | $1.47B |
| Q2 2022 | 223 | $1.91B |
| Q1 2022 | 239 | $2.06B |
| Q4 2021 | 258 | $2.14B |
| Q3 2021 | 246 | $1.62B |
| Q2 2021 | 273 | $2.35B |
| Q1 2021 | 276 | $2.11B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Nu Skin Enterprises, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 551,741 | $10.7M | 0.00% | −3,413−0.6% | Reduced |
| Aristotle Capital Boston, LLC | 799,168 | $15.5M | 0.47% | +20,399+2.6% | Added |
| Bank of New York Mellon Corp | 836,550 | $16.2M | 0.00% | +69,108+9.0% | Added |
| Morgan Stanley | 974,883 | $18.9M | 0.00% | −129,025−11.7% | Reduced |
| Geode Capital Management, LLC | 1,064,233 | $20.7M | 0.00% | −27,607−2.5% | Reduced |
| Charles Schwab Investment Management Inc | 1,157,697 | $22.5M | 0.01% | +173,193+17.6% | Added |
| Dimensional Fund Advisors LP | 1,392,882 | $27.0M | 0.01% | −345,859−19.9% | Reduced |
| Renaissance Technologies LLC | 1,928,696 | $37.5M | 0.06% | −65,600−3.3% | Reduced |
| Invesco Ltd. | 2,856,897 | $55.5M | 0.01% | +1,162,785+68.6% | Added |
| State Street Corp | 2,871,749 | $55.8M | 0.00% | −131,676−4.4% | Reduced |
| Vanguard Group Inc | 6,215,271 | $120.7M | 0.00% | −20,224−0.3% | Reduced |
| BlackRock Inc. | 8,508,678 | $165.2M | 0.00% | +462,531+5.7% | Added |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −143,733−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −102,879−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −76,974−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −61,100−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −52,709−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −39,891−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −35,752−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −27,792−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −25,600−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −18,655−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −17,785−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −15,883−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −13,966−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −13,864−100.0% | Sold out |
| Kendall Capital Management | 0 | $0 | 0.00% | −13,475−100.0% | Sold out |
| Clearview Wealth Advisors LLC | 0 | $0 | 0.00% | −12,962−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −12,637−100.0% | Sold out |
| Ingalls & Snyder LLC | 0 | $0 | 0.00% | −10,882−100.0% | Sold out |
| Trilogy Capital Inc. | 0 | $0 | 0.00% | −10,009−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −9,998−100.0% | Sold out |
| Counterpoint Mutual Funds LLC | 0 | $0 | 0.00% | −5,836−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −3,825−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −718−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −592−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Armstrong Advisory Group, Inc | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Earnest Partners LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |